drugset / Trial / NCT06254014
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main purpose of this study is to investigate the efficacy and safety of JY09 versus placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled by diet and exercise alone
Timeline
- Start
- 2024-07-10
- Primary completion
- 2026-05-01
- Completion
- 2026-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exendin-4Fc fusion protein | Protein / enzyme biologic | 1.2 mg | Subcutaneous |
| Subject | Exendin-4Fc fusion protein | Protein / enzyme biologic | 2.4 mg | Subcutaneous |